These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35997948)

  • 1. Note by Hormones' new editor: metabolic syndrome plus obesity and COVID-19, the two concurrent pandemics and the field of endocrinology.
    Stratakis CA
    Hormones (Athens); 2022 Sep; 21(3):347-348. PubMed ID: 35997948
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity and impaired metabolic health in patients with COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB; Ludwig DS
    Nat Rev Endocrinol; 2020 Jul; 16(7):341-342. PubMed ID: 32327737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health.
    Auriemma RS; Pirchio R; Liccardi A; Scairati R; Del Vecchio G; Pivonello R; Colao A
    J Endocrinol Invest; 2021 Dec; 44(12):2845-2847. PubMed ID: 34037973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic cardiometabolic conditions and mental health during COVID-19.
    Farooqi AT; Snoek FJ; Khunti K
    Prim Care Diabetes; 2021 Feb; 15(1):21-23. PubMed ID: 32917554
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and metabolic syndrome: could diet be the key?
    Demasi M
    BMJ Evid Based Med; 2021 Feb; 26(1):1-2. PubMed ID: 32651302
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity.
    Kim NH; Kim KJ; Choi J; Kim SG
    Metabolism; 2022 Mar; 128():154894. PubMed ID: 34600905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research, adapt, and overcome: Changes in submission rates to endocrinology scientific journals during the COVID-19 pandemic.
    Noyman DBE; Khamaisi M
    Front Endocrinol (Lausanne); 2022; 13():998269. PubMed ID: 36120441
    [No Abstract]   [Full Text] [Related]  

  • 9. The vicious cycle: a history of obesity and COVID-19.
    Bil J; Możeńska O
    BMC Cardiovasc Disord; 2021 Jul; 21(1):332. PubMed ID: 34229605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Perspectives on the COVID-19 Vaccine: A Pilot Survey Study of Patients in Endocrinology Clinics.
    Mikkilineni P; Simon R; Bhan A; Rao SD
    Endocr Pract; 2022 Sep; 28(9):897-900. PubMed ID: 35787467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.
    Puig-Domingo M; Marazuela M; Giustina A
    Endocrine; 2020 Apr; 68(1):2-5. PubMed ID: 32279224
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter to the Editor.
    Zhu J
    Endocr Pract; 2017 Jul; 23(7):887. PubMed ID: 28703652
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19: the endocrine opportunity in a pandemic.
    Chatterjee S; Ghosh R; Biswas P; Dubey S; Guria RT; Sharma CB; Kalra S
    Minerva Endocrinol; 2020 Sep; 45(3):204-227. PubMed ID: 32548995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APPLICATION OF THE AACE/ACE ADVANCED FRAMEWORK FOR THE DIAGNOSIS OF OBESITY AND CARDIOMETABOLIC DISEASE STAGING IN A GENERAL POPULATION FROM 3 REGIONS OF VENEZUELA: THE VEMSOLS STUDY RESULTS.
    Nieto-Martínez R; González-Rivas JP; Ugel E; Brajkovich I; Risquez A; Garvey WT; Mechanick JI
    Endocr Pract; 2018 Jan; 24(1):6-13. PubMed ID: 29106817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis.
    O'Hearn M; Liu J; Cudhea F; Micha R; Mozaffarian D
    J Am Heart Assoc; 2021 Feb; 10(5):e019259. PubMed ID: 33629868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].
    Martínez Urbistondo M; Mora Vargas A; Expósito Palomo E; Aparicio de Miguel M; Castejón Díaz R; Daimiel L; Ramos López O; San Cristóbal R; Martínez JA; Vargas Núñez JA
    Nutr Hosp; 2021 Oct; 38(5):1068-1074. PubMed ID: 34176273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year of the pandemic - how European endocrinologists responded to the crisis: a statement from the European Society of Endocrinology.
    Giustina A; Marazuela M; Reincke M; Yildiz BO; Puig-Domingo M
    Eur J Endocrinol; 2021 Jul; 185(2):C1-C7. PubMed ID: 34132200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variance of concern.
    Oliver N
    Diabet Med; 2022 Feb; 39(2):e14782. PubMed ID: 35015313
    [No Abstract]   [Full Text] [Related]  

  • 19. Covid-19 and Metabolic Syndrome.
    Chocair PR; Neves PDMM; Pereira LVB; Mohrbacher S; Oliveira ES; Nardotto LL; Bales AM; Sato VAH; Ferreira BMC; Cuvello Neto AL
    Rev Assoc Med Bras (1992); 2020 Jul; 66(7):871-875. PubMed ID: 32844933
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action.
    Hill MA; Sowers JR; Mantzoros CS
    Metabolism; 2021 Jan; 114():154408. PubMed ID: 33080269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.